What does the Anti-Markup Rule prevent concerning Medicare diagnostic tests?

• A. Prohibits sharing of patient data between physicians
• B. Prohibits the markup of both technical and professional components
• C. Allows physicians to bill at inflated rates
• D. Encourages competition among diagnostic providers

Answer: (B)

The Anti-Markup Rule is part of the regulations set forth by Medicare to ensure fair and reasonable billing practices for diagnostic tests. It specifically addresses the scenario where a physician or medical practice bills for diagnostic services provided by others. The primary purpose of this rule is to prevent physicians from marking up the cost of services they did not directly provide, ensuring that patients and payors are not charged excessively based on a business relationship rather than the actual cost of the service.

By prohibiting the markup of both the technical and professional components of a diagnostic test, the rule promotes transparency and accountability in billing. It ensures that the physician who performs the service directly is accurately compensated for their work without unnecessary inflation of costs from other providers who might be involved in the process. This protection is important for maintaining trust in the healthcare system and safeguarding against potential abuses in billing practices.

The other options do not accurately reflect the focus of the Anti-Markup Rule: sharing of patient data is not addressed by this rule, nor does the rule encourage inflated billing or necessarily enhance competition among providers in a way that justifies price increases.